What We're Reading: Page 174
Industry reads hand-picked by our editors
Oct 02, 2020
-
Forbes
The Scientologist Billionaire Trying To Make A New Antibiotic
-
Science
FDA's own documents reveal agency's lax, slow, and secretive oversight of clinical research
-
STAT
Democrats press Amgen, Novartis, Mallinckrodt on pricing tactics
-
The Wall Street Journal
Telehealth Startup Hims Strikes Deal to Go Public Through SPAC
Oct 01, 2020
Sep 30, 2020
-
The Washington Post
7 former FDA commissioners: The Trump administration is undermining the credibility of the FDA
-
STAT
Catalyst loses lawsuit accusing the FDA of unfairly approving rival drug
-
Science
On the road with Operation Warp Speed, the U.S. COVID-19 vaccine effort
-
Endpoints News
Brent Saunders rides $400M wave to the top of the SPAC boom
Sep 29, 2020
Sep 28, 2020
Sep 25, 2020
-
The New York Times
New York Will Review Virus Vaccines, Citing Politicization of Process
-
The Wall Street Journal
A Bet on Europe Is a Bet on Drugs, Against Tech
-
Bloomberg
Opioid Distributors Get ‘Negotiation Class’ Tossed on Appeal
-
BioCentury
Gilead’s bid for Immunomedics exceeded rival offer by nearly $8B
Previous
